FDA Clears Dishman's API Facility In Naroda, India
Published: 06-Feb-2010
FDA has approved Dishman Pharmaceuticals and Chemicals' (Dishman) Naroda facility in India for the manufacturing of Active Pharmaceutical Ingredients (API).
The FDA had a thorough inspection of the Naroda facility and cleared after it was found to be suitable for manufacturing export-purpose APIs.
The facility is an Export Oriented Unit (EOU) and will manufacture the APIs for the US markets. It was established with the help of Carbogen Amcis and its technical team. Carbogen Amcis is a Swiss subsidiary of Dishman Pharma.
Reportedly, the company is planning to start two new API units with an investment of INR1.25-1.5bn next year. Earlier, Dishman had announced its expansion plan wherein it declared an investment of INR1.25bn capex plan by the end of March this year.
Additionally, the company's API facility in Ahmedabad, India, manufactures a range of oncology APIs and other related high potency products.
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
Burkert Fluid Control Systems
Fluid and Gas Control Systems ...
ADAPT Localization
The Translation and Localization Specialists ...
BINDER
Best Conditions for Your Success ...
BIOQUELL
Specialist Providers of Bio-decontamination Equipment and Services ...
Medilingua Translations
The Medical Translation Specialists ...
PreSens Precision Sensing
Sensors for Industry and Research ...
White Papers
Browse A-Z
CaseBase Management
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...
SafetyBase Interchange
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...
ClinicalBase Trial
BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...
Reliable Prediction of White Plasma Levels
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
Kinetics and Metabolism
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
Drug Safety Evaluation
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
